GlassScriptPhysician profile
Justin Philip
NPI 1477916518
$2,592.19
in general payments reported to CMS, 2019-2025
20 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2022: $1,626 · 2023: $159 · 2024: $331 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,750.10 | 2022-2023 | Da Vinci Surgical System |
| Covidien LP | $225.78 | 2019 | |
| W. L. Gore & Associates, INC. | $132.57 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Tela Bio, INC. | $56.45 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Eisai INC. | $47.64 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $47.58 | 2025 | Ultomiris |
| Reflow Medical INC | $33.52 | 2024 | |
| Medtronic, INC. | $31.00 | 2022-2025 | Biosyn |
| Astrazeneca Pharmaceuticals LP | $30.73 | 2025 | Enhertu |
| Genmab U.S., INC. | $30.54 | 2024 | Tivdak |
| Daiichi Sankyo INC. | $24.70 | 2025 | Enhertu |
| Pacira Pharmaceuticals Incorporated | $23.96 | 2025 | Exparel |
| Davol INC. | $21.77 | 2023 | Phasix Mesh |
| Mozarc Medical US LLC | $21.10 | 2024 | Argyle |
| Lilly USA, LLC | $20.72 | 2024 | Verzenio |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.55 | 2024 | Ninlaro |
| Stemline Therapeutics INC. | $20.29 | 2025 | Orserdu |
| Urgo Medical North America, LLC | $18.24 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Advanced Accelerator Applications | $18.18 | 2019 | |
| Smith+Nephew, INC. | $16.77 | 2025 | Pico 14 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Philip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.